This may result in sense loss, difficulty in proprioception, neuropathic pain, difficulty walking, poor balance, loss of sensation in the feet, muscle weakness, blurred vision (either due to retinopathy [27] or optic neuropathy [28] ), impaired urination, fertility problems, decreased sense of taste and smell, decreased level of consciousness, changes in reflexes, memory loss, mood swings, depression, irritability, cognitive impairment, confusion, anxiety, clumsiness, dementia, and, in more severe cases, psychosis
Your dose may need to go up, your medication may need to change, but your price won't increase with dose adjustments
The Medicare Procedure Price Lookup tool at Medicare.gov provides national average costs for CPT 62323 across ASC and HOPD settings and is updated as new fee schedule data becomes available
Compounded versions are not FDA-approved brand products
On the same measure, cumulative revenues across the major pharmaceutical companies alone are projected to reach close to $165 billion by 2030 (Figure 1)
The clearest signal that it might be time to increase is a plateau
